Has been forgotten by the market as usual. But if the next results - due any time - confirm the pre-clinical results then it should move up.
It took IMU 4-5 years to get recognized by the market, therefore a few weeks to wait should be acceptable.
I think that the management isn't really aware of what the cancer results actually mean compared to what is currently developed. And that's no surprise as they are business people with limited or no medical background. Dr Stephens, in charge of the clinical part, seems to be the only one with comprehensive knowledge. That's a difference to IMU where everyone of the team has at least a scientific background.
But I could be wrong and Team IVX is already planning big things in the background.
GLTA
IVX Price at posting:
1.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)